The latest price target for Arcturus Therapeutics (NASDAQ:ARCT) was reported by Canaccord Genuity on March 10, 2025. The analyst firm set a price target for $68.00 expecting ARCT to rise to within ...

Meanwhile Arcturus, a San Diego biotech working with messenger RNA (mRNA) therapies said it is working with Duke-NUS Medical School (Duke-NUS) to develop a coronavirus vaccine for Singapore.

The AK-OTOF therapy remains in early-stage clinical testing, but the success in the first patient to receive it – an 11-year-old boy who was profoundly deaf, but whose hearing is now reported to ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

The responses to my last video about the Division of Elections have been interesting to me. The biggest surprise was the number of people asking me to run for Lt Governor, however Ranked Choice voting ...